Clorox (CLX) Misses Q4 EPS by 41c, Guidance Falls Short of Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Clorox (CLX) Falls Sharply as COVID-19 Demand Wanes
August 3, 2021 7:59 AM EDTShares of Clorox (NYSE: CLX) are down about 10% in pre-open Tuesday after the company saw fading demand for its products.
The companys biggest unit by revenue generated, the health and wellness division, witnessed a 17% decline in sales. The company recorded falling sales in three out of four business divisions as pandemic-shaped demand for Clorox waned.
Overall, sales... More
